NCT01041937

Brief Summary

The primary purpose of TKA Randomized Clinical Trial- Cemented versus Cementless Tibial Prosthesis Study will determine whether there is a significant difference in patient-reported and measured clinical outcomes (e.g. pain, function, length of recovery, and patient satisfaction) between subjects treated with a cementless tibial prosthesis (the cementless group) and those treated with cemented tibial prosthesis (the cement group) over the first two postoperative years. Radiographs will be assessed before surgery and at established post-operative intervals to determine if there are any significant differences between patients in the two groups and to assess the influence of component fixation on radiographic stability over time. Complication and revision rates will also be assessed for comparison.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

January 8, 2019

Status Verified

January 1, 2019

Enrollment Period

2 years

First QC Date

January 4, 2010

Last Update Submit

January 4, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • To use clinical outcome measures to assess for differences in patient function, quality of life and satisfaction between patients who have tibial component placement with either a cemented or a cementless technique

    2014

Study Arms (2)

Cemented Tibia

ACTIVE COMPARATOR

Assessing the clinical outcomes of the different type of fixation

Procedure: Cemented Tibia

Cementless Tibia

ACTIVE COMPARATOR

Assessing the clinical outcomes of the different type of fixation

Procedure: Cementless Tibia

Interventions

Total knee arthroplasty with cemented or cemented tibia, and post operative clinical outcome tracking

Cemented Tibia

Assessing the clinical outcomes of the different type of fixation

Cementless Tibia

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI less than \<35
  • Normal neurological function
  • Primary total knee arthroplasty (Pre operative Medial Knee Patient)
  • Patient age ≤ 70 years old

You may not qualify if:

  • Revision surgery
  • History of joint sepsis
  • Recent systemic corticosteroids (\< 2 months prior to procedure)
  • Primary or secondary carcinoma in the last five years
  • Post operative renal transplant
  • Psychosocial disorders limiting rehabilitation
  • Previous intraarticular knee fracture
  • Over 20° valgus or varus deformity
  • Extension loss over 20°
  • Unsuitable for cruciate- substituting arthroplasty
  • Unsuitable for cementless fixation of the tibial component
  • Need for augmentation wedges or bone graft
  • Previous proximal tibial osteotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

OsteoarthritisArthritis, Rheumatoid

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • John Clohisy, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2010

First Posted

January 5, 2010

Study Start

December 1, 2009

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

January 8, 2019

Record last verified: 2019-01

Locations